CIK 0001583771 · Non-accelerated filer<br>Smaller reporting company
Hepion Pharmaceuticals, Inc.
Sign in to watch- Tickers
- HEPA CTRVP
- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 462783806
- Phone
- 732-902-4000
- Business address
- 34 SHREWSBURY AVE., SUITE 1D, RED BANK, NJ, 07701
- Former names
- ContraVir Pharmaceuticals, Inc.
Securities
- HEPA Common stock OTC
- CTRVP Common stock OTC
- Open-market buys, last 90 days
- $10,000
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$10,000. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 28 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-02-19 | JACOB GARY S Director | Grant or award · Stock Options | +85,000 | 102,120 | ||
| 2023-11-27 | Wijngaard Peter Director | Purchase | +2,500 | $3.05 | $8K | 9,501 |
| 2023-11-24 | Wijngaard Peter Director | Purchase | +2,500 | $3.09 | $8K | 7,001 |
| 2023-09-19 | Wijngaard Peter Director | Purchase | +1,000 | $5.64 | $6K | 4,501 |
| 2023-09-18 | Foster Robert T CEO and Director | Purchase | +1,600 | $5.60 | $9K | 50,470 |
| 2023-09-15 | Wijngaard Peter Director | Purchase | +1,000 | $5.82 | $6K | 2,501 |
| 2023-09-15 | Wijngaard Peter Director | Purchase | +139 | $5.45 | $758 | 2,640 |
| 2023-09-15 | Wijngaard Peter Director | Purchase | +861 | $5.37 | $5K | 3,501 |
| 2023-09-15 | Foster Robert T CEO,CSO and Director | Purchase | +1,600 | $5.40 | $9K | 48,870 |
| 2021-05-18 | Lippa Arnold Director | Grant or award · Stock Options | +200,000 | 291,110 | ||
| 2021-05-18 | Wijngaard Peter Director | Grant or award · Stock Options | +200,000 | 260,000 | ||
| 2021-05-18 | JACOB GARY S Director | Grant or award · Stock Options | +250,000 | 342,785 | ||
| 2021-05-18 | Foster Robert T CEO, CSO and Director | Grant or award · Stock Options | +1,900,000 | 2,501,879 | ||
| 2021-05-18 | Cavan John T Chief Financial Officer | Grant or award · Stock Options | +1,200,000 | 1,581,060 | ||
| 2021-05-18 | BRANCACCIO JOHN P Director | Grant or award · Stock Options | +200,000 | 291,332 | ||
| 2021-05-18 | Block Timothy M. Director | Grant or award · Stock Options | +200,000 | 291,276 | ||
| 2021-05-18 | ADAMS THOMAS PHD Director | Grant or award · Stock Options | +200,000 | 291,050 | ||
| 2021-02-18 | Foster Robert T CEO and Director | Purchase | +20,000 | $2.00 | $40K | 45,259 |
| 2021-02-18 | Cavan John T Chief Financial Officer | Purchase | +10,000 | $2.00 | $20K | 14,800 |
| 2021-02-16 | Wijngaard Peter Director | Purchase | +10,000 | $2.20 | $22K | 30,000 |
Page 3 of 6 · 119 trades